68 results on '"Motwani M"'
Search Results
2. 214MO Sacituzumab govitecan (SG) efficacy in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) metastatic breast cancer (MBC) by HER2 immunohistochemistry (IHC) status in the phase III TROPiCS-02 study
3. List of Contributors
4. Role of Novel Imaging Techniques in Detection of Chemotoxicity: Cardiac Magnetic Resonance and Radionuclide Imaging
5. MO31-2 Telisotuzumab vedotin monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer
6. Contributors
7. Cardiac tumours
8. Machine learning from quantitative coronary computed tomography angiography predicts ischemia and impaired myocardial blood flow
9. P60.12 Prevalence of c-Met overexpression (c-Met+) and Impact of Prior Lines of Treatment on c-Met Protein Expression in NSCLC
10. P47.03 Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met+ Advanced Non-Small Cell Lung Cancer: Stage 2
11. Machine Learning From Quantitative Coronary Computed Tomography Angiography Predicts Ischemia And Impaired Myocardial Blood Flow
12. P323Triage-HF Plus: identification of heart failure and non-heart failure events in an ambulatory population using remote monitoring and the triage heart failure risk score Algorithm
13. P2.01-19 Phase 2 Study of Telisotuzumab Vedotin (Teliso-V) in Previously Treated c-MET+ Non-Small Cell Lung Cancer: Trial in Progress
14. First-in-human study of ABBV-621 in patients (pts) with previously treated sold tumours: Dose-optimization cohorts
15. MA14.03 EGFR M+ Subgroup of Phase 1b Study of Telisotuzumab Vedotin (Teliso-V) Plus Erlotinib in c-Met+ Non-Small Cell Lung Cancer
16. Circulating tumour DNA (ctDNA) analysis in patients (pts) with non-small cell lung cancer (NSCLC) treated with telisotuzumab vedotin (teliso-v), an antibody-drug conjugate targeting c-Met
17. P124Sequential CT coronary angiography and 82-Rb positron emission tomography: Defining the quantitative relationships between coronary artery calcium, coronary stenosis and myocardial blood flow reserve
18. An open-label, multicenter, phase I study of ABBV-399 (telisotuzumab vedotin, teliso-V) as monotherapy (T) and in combination with erlotinib (T+E) in non-small cell lung cancer (NSCLC)
19. Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)
20. ABT-165 plus FOLFIRI vs bevacizumab plus FOLFIRI in patients with metastatic colorectal cancer (mCRC) previously treated with fluoropyrimidine/oxaliplatin and bevacizumab - Trial in progress
21. MA 02.10 Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC
22. P1.04-006 Rovalpituzumab Tesirine vs Topotecan in Patients with Advanced Small Cell Lung Cancer Following 1st Line Chemotherapy
23. 84Single-centre experience of cied lead extraction using cook medical evolution system
24. 22Cied lead extraction in the elderly has low risk
25. A phase 3 trial of rovalpituzumab tesirine vs topotecan in patients with advanced small cell lung cancer following frontline platinum-based chemotherapy
26. P045 5-Aminosalicylates promote inflammation resolution in ulcerative colitis through generation of anti-inflammatory hydroxy fatty acids
27. P043 Ulcerative colitis is characterised by an exaggerated onset of acute inflammation with delayed resolution
28. Modeling the initiation of Ewing sarcoma tumorigenesis in differentiating human embryonic stem cells
29. 20 Myocardial extracellular volume predicts functional recovery in acute myocardial infarction more accurately than threshold-based measures of late gadolinium enhancement transmural extent
30. 22 Surgical aortic valve replacement (SAVR) upon right ventricular function: a cardiac mri study: Abstract 22 Table 1
31. 21 Left atrial remodelling following treatment of symptomatic severe aortic stenosis
32. Fractional flow reserve is a useful reference standard for myocardial perfusion studies with limitations: reply
33. Assessment of ischaemic burden in angiographic three-vessel coronary artery disease with high-resolution myocardial perfusion cardiovascular magnetic resonance imaging
34. Contractile recovery of infarct zone in reperfused acute myocardial infarction is influenced by microvascular obstruction and intramyocardial hemorrhage
35. Fractional flow reserve as the reference standard for myocardial perfusion studies: fool's gold?
36. 089 REGIONAL VARIATION IN MYOCARDIAL BLOOD FLOW IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK: A QUANTITATIVE PERFUSION CMR STUDY
37. 144 A CEREBRAL DIFFUSION WEIGHTED MRI STUDY TO ASSESS THE DIFFERENCE BETWEEN EMBOLIC EVENTS FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) AND SURGICAL AORTIC VALVE REPLACEMENT (SAVR)
38. 097 FACTORS ASSOCIATED WITH FALSE NEGATIVE CARDIOVASCULAR MAGNETIC RESONANCE PERFUSION STUDIES: A CE-MARC SUBSTUDY
39. 145 AORTIC REGURGITATION AFTER COREVALVE TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI): ASSESSMENT BY ECHOCARDIOGRAPHY AND CARDIOVASCULAR MAGNETIC RESONANCE
40. 092 MICROVASCULAR OBSTRUCTION AND INTRAMYOCARDIAL HAEMORRHAGE INFLUENCES INFARCT ZONE CONTRACTILE RECOVERY IN REPERFUSED ACUTE MYOCARDIAL INFARCTION
41. 091 QUANTITATIVE THREE-DIMENSIONAL CARDIOVASCULAR MAGNETIC RESONANCE MYOCARDIAL PERFUSION IMAGING IN SYSTOLE AND DIASTOLE AT 3.0 T
42. 095 VISUAL AND QUANTITATIVE ANALYSIS OF MYOCARDIAL PERFUSION IN LEFT MAIN STEM DISEASE: A CE-MARC SUBSTUDY
43. 093 RECIPROCAL ECG CHANGE IN ST-ELEVATION MYOCARDIAL INFARCTION IS ASSOCIATED WITH AREA AT RISK AND MYOCARDIAL SALVAGE FOLLOWING REVASCULARIZATION
44. 088 Comparison of cardiovascular magnetic resonance stress perfusion with single photon emission CT (SPECT) in patients with left main stem disease: a CE-MARC substudy
45. 042 Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement. A cardiovascular magnetic resonance study
46. 041 Serial change in health related quality of life over 1 year following transcatheter aortic valve implantation: predictors of health outcomes
47. 089 Regression of myocardial oedema is related to improvement in myocardial contractility following reperfused acute myocardial infarction
48. 086 Assessment of ischaemic burden in patients with three-vessel coronary artery disease using high-resolution myocardial perfusion cardiovascular MRI
49. 085 Systolic vs diastolic acquisition in cardiovascular magnetic resonance myocardial perfusion imaging
50. 070 Enzyme replacement therapy improves cardiac features of Fabry disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.